Neuroscience

Bon Secours is Virginia’s largest Joint Commission/American Heart Association certified stroke center network with 9 sites providing the most advanced treatment options available.

Disorders of the brain and central nervous system—such as migraines, epilepsy, tumors, stroke and Alzheimer’s disease—are as complex as the brain itself. At Bon Secours Neuroscience Institute, our board-certified team of neurology, neurosurgical, neurointerventional, neuroradiology and neuropsychology experts combine compassionate care with the most advanced medical treatments to help patients with nervous system conditions maintain their highest quality of life.

Sharing Expertise. Saving Lives.

The Bon Secours Neuroscience Institute serves patients in eight acute care facilities in Richmond, Hampton Roads and Rappahannock. Patients at each location benefit from the expertise of all Bon Secours’ physicians, thanks to an advanced teleneurology system—the largest stroke teleneurology network in Virginia—that enables a board-certified neurologist to link to other doctors via a high-definition video to quickly evaluate patients with neurologic emergencies.

This lifesaving technology has allowed Bon Secours to provide faster treatment for stroke patients with a clot-busting drug called tPA. Stroke patients who receive this critical treatment within three hours of having symptoms have a greater likelihood of survival and may suffer less damage. However, because many patients do not recognize the signs of a stroke, they often delay treatment, making the need for teleneurology so critical.

Quality Measures

The providers and staff at the Bon Secours Neuorscience Institute provide the highest quality of care for our patients.

View our quality measures

The information below is an overview of key performance measures for Bon Secours St. Mary’s Hospital from 09/01/2014-08/31/2015.

Ischemic and hemorrhagic stroke patients who received VTE prophylaxis or have documentation why no VTE prophylaxis was given the day of or the day after hospital admission.

National Performance Goal: 85%
St. Mary’s Hospital 90.6%
Ischemic stroke patients prescribed antithrombotic therapy at hospital discharge.

National Performance Goal: 85%
St. Mary’s Hospital 97.7%
Ischemic stroke patients with atrial fibrillation/flutter who are prescribed anticoagulation therapy at hospital discharge.

National Performance Goal: 85%
St. Mary’s Hospital 94.4%
Acute ischemic stroke patients who arrive at this hospital within 2 hours of time last known well and for whom IV t-PA was initiated at this hospital within 3 hours of time last known well.

National Performance Goal: 85%
St. Mary’s Hospital 100%
Ischemic stroke patients administered antithrombotic therapy by the end of hospital day 2.

National Performance Goal: 85%
St. Mary’s Hospital 97.7%
Ischemic stroke patients who are prescribed statin medication at hospital discharge.

National Performance Goal: 85%
St. Mary’s Hospital 95.8%
Ischemic or hemorrhagic stroke patients or their caregivers who were given educational materials during the hospital stay addressing all of the following:activation of emergency medical system, need for follow-up after discharge, medications prescribed at discharge, risk factors for stroke, and warning signs and symptoms of stroke.

National Performance Goal: 85%
St. Mary’s Hospital 90.9%
Ischemic or hemorrhagic stroke patients who were assessed for rehabilitation services.

National Performance Goal: 85%
St. Mary’s Hospital 97.7%

Stroke Mortality

National Performance Goal: 7%
St. Mary’s Hospital 6.7%

Related Practices